MOTS-c Pharmacokinetics: Route & Clearance Comparison
Subcutaneous Injection 30–60 minutes 70–85 ~4 hours 5–8 mL/min/kg Standard research route. Predictable absorption, moderate bioavailability, requires daily dosing to maintain plasma levels Intranasal Spray 10–20 minutes 50–65 ~3.5 hours Faster CNS delivery, lo
This comparison does not assign a generated winner or score.
- Subcutaneous Injection
- 30–60 minutes
- 70–85
- ~4 hours
- 5–8 mL/min/kg
- Standard research route. Predictable absorption, moderate bioavailability, requires daily dosing to maintain plasma levels
- Intranasal Spray
- 10–20 minutes
- 50–65
- ~3.5 hours
- Faster CNS delivery, lower systemic AUC. Useful for neurometabolic studies but less sustained peripheral effect
- Intravenous Bolus
- Immediate (0–5 min)
- 100
- Research-only route for precise pharmacokinetic studies. Impractical for repeated dosing outside controlled settings
- Oral Administration
- Not applicable
- <5
- Non-viable. Peptide bonds hydrolysed by gastric acid and digestive enzymes before absorption; negligible systemic exposure